UCSF sci­en­tist rolls out a new blue­print for pro­gram­ming T cells, the 2.0 way

While an­a­lysts de­bate about whether or not the FDA will be will­ing to hand out the first CAR-T ap­proval to Kite, the sci­en­tists in this bur­geon­ing field have been la­bor­ing in the lab on next-gen T cell ther­a­py mod­els that have a lot more built-in safe­ty and ef­fi­ca­cy fea­tures. One of the top cell ther­a­py en­gi­neers is Wen­dell Lim at UC San Fran­cis­co, the sci­en­tif­ic founder of Cell De­sign Labs. And he’s just come out with a new pa­per on his work fea­tur­ing some of the cool new tech­nolo­gies that he’s been us­ing on T cells 2.0.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.